Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ionis Pharmaceuticals Q3 Adj. EPS $(0.61) Beats $(1.23) Estimate, Sales $157.000M Beat $130.920M Estimate

Author: Benzinga Newsdesk | October 29, 2025 06:02am
Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(1.23) by 50.32 percent. This is a 14.86 percent increase over losses of $(0.72) per share from the same period last year. The company reported quarterly sales of $157.000 million which beat the analyst consensus estimate of $130.920 million by 19.92 percent. This is a 17.16 percent increase over sales of $134.000 million the same period last year.

Posted In: IONS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist